5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Tatva Chintan Pharma Chem Ltd.

•
tatvachintan.comBSE: 543321NSE: TATVA
Market Cap₹ 3,786 Cr.
Current Price
High / Low₹ 1,838 / 976
Stock P/E73.7
Book Value₹ 341
Price to Book3.14
Dividend Yield0.12 %
ROCE7.2 %
ROE5.5 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Structure Directing Agents: 40.4% • Pharmaceutical & Agrochemical intermediates & Other Specialty Chemicals: 32.0% • Phase Transfer Catalysts: 23.2%

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence
55%
View full sector analysis →

PROS

  • Latest quarter profit grew 140.3% YoY, showing strong momentum
  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.98x)
  • Working capital cycle has improved - days down from 161 to 98
  • Company comfortably covers its interest (19.2x coverage)
  • Company has a consistent dividend-paying track record

CONS

  • Company has a low return on capital employed of 5.1%
  • Company has a low return on equity of 3.7% over last 3 years
  • Free cash flow has been persistently negative
  • Total debt has risen sharply - up 230.8% year on year
  • Company has delivered a poor profit growth of -4.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SOLARINDS20550.0093.38185957.060.05666.3788.983668.2070.2638.1627.91
2.PIDILITIND1636.4062.88166565.831.318835.101202.8645515.501112.7432.3826.28
3.SRF2597.0035.6176981.530.35758.8775.535033.2634.6314.2124.57
4.FLUOROCHEM4731.2584.5151972.780.06219.0019.021588.0023.979.5826.83
5.NAVINFLUOR8538.2555.4743808.150.18243.31107.671045.0844.0721.3934.17
6.GODREJIND1138.5532.6238352.180.00523.36-27.855448.0922.1610.6412.82
7.DEEPAKNTR1733.6530.1923645.780.43345.01207.362577.6036.3911.5820.96
8.AETHER1646.0592.8921847.670.0062.7533.45326.5627.4911.6531.47
9.ATUL6484.4024.0019091.210.46253.9391.851847.9525.0315.0521.41
10.AARTIIND505.4534.5318334.020.20155.00260.472387.0042.426.9516.00
11.DEEPAKFERT1417.1018.2417949.400.71490.04100.953256.2622.4712.1225.96
12.TATVA1618.4073.683785.770.1215.98140.28167.0642.957.1719.33
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1149784981058386108117124131134167
9376738393787999100101106106147
Operating Profit21201116136791722252832
OPM %18.66%20.94%13.05%15.87%11.97%6.68%8.22%8.31%14.82%17.98%19.41%20.98%19.33%
Other Income11151001112-03
Interest3300000001012
Depreciation677677779991011
13115147-1-02914181721
Tax %29.21%30.60%34.16%29.80%23.49%35.29%154.17%49.26%26.92%27.45%14.10%37.79%24.30%
Net Profit00005-101710151016
43142-00034641
Equity Capital22232323232323232323232323
Reserves0000000000000
Promoter Pledge %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
135206263300434424394383506556
114172208234325363325348412461
Operating Profit2635577211867763797—
OPM %191722242716191019—
Other Income5015968245
Interest3444597235
Depreciation445781026283738
20274861104454485769
Tax %332521148-230252626
Net Profit1321385296453064251
EPS16101926452113218—
Dividend Payout %00019510154111—
Minority Interest0000000000
Share of Associates0000000000
Adjusted EPS6101926432113218—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
11%
3 Years:
6%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-4%
3 Years:
-3%

STOCK PRICE CAGR

10 Years:
—
5 Years:
-5%
3 Years:
-3%
1 Year:
49%

RETURN ON EQUITY

10 Years:
—
5 Years:
10%
3 Years:
4%
Last Year:
6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 11

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2025

Sep 12

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

2024

Sep 6

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2023

Sep 8

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2022

Sep 8

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2022

Apr 25

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2026

Aug 27

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
LIABILITIES---------
Equity Capital888202222232323
5472110146451493714715758
364040631071661036114
Trade Payables252232474532453358
244659482531141640
Total Liabilities147188249325649744807824994
ASSETS---------
5667111120160196427529609
Capital Work in Progress10651051231732223
1000001004
29366472170162153134196
0000007090119
Cash & Bank9161151774538149
42635811891110363633
Total Assets147188249325649744807824994
Total Debt567791901201701436120
Net Working Capital1842456626474218169136
Contingent Liabilities0011316712
Book Value per Share77.4199.19146.4882.62213.44232.25315.10315.84334.20
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
0725202028982531
Cash from Investing0-17-40-21-197-101-121-65-116
Cash from Financing01710-523538311779
08-5-659-368-24-5
Free Cash Flow07-23-2-69-197-0-53-86
OCF / Net Profit0.000.360.670.380.210.613.234.340.75
Cumulative 5-Year FCF00000-283-290-321-405

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
PER SHARE
EPS (₹)16.1825.5747.0326.0243.2520.5212.982.4417.98
Book Value (₹)77.4199.19146.4882.62213.44232.25315.10315.84334.20
Dividend per Share (₹)0.000.000.005.002.002.002.001.002.00
Cash EPS (₹)8.2612.2321.2029.3746.9524.8323.9214.2733.73
PROFITABILITY
Operating Margin %19.40%16.78%21.52%23.90%27.09%15.70%17.33%8.99%18.45%
Net Margin %9.60%9.96%14.36%17.38%22.10%10.73%7.69%1.49%8.30%
ROE %20.90%28.95%38.29%36.85%30.01%9.21%4.85%0.77%5.53%
ROCE %19.15%22.78%28.40%28.04%25.75%8.35%7.00%1.19%7.17%
8.83%12.28%17.32%18.21%19.68%6.53%3.91%0.70%4.63%
EFFICIENCY
Debtor Days856563856261717675
Inventory Days79586982102143146137119
Payable Days1287574958662817174
3747587278142136141120
FINANCIAL HEALTH
Debt to Equity (x)0.90x0.97x0.77x0.54x0.25x0.33x0.02x0.05x0.15x
Interest Coverage (x)7.18x7.94x12.15x14.65x20.90x6.21x7.47x6.01x19.16x
1.28x1.57x1.51x1.52x2.54x1.31x3.74x2.76x1.64x
GROWTH
Revenue Growth %0.00%52.30%27.60%14.10%44.38%-2.31%-7.11%-2.74%32.18%
Operating Profit Growth %0.00%31.72%63.71%26.86%63.52%-43.40%14.10%-51.58%163.93%
Net Profit Growth %0.00%58.03%83.95%38.30%83.45%-52.56%-33.27%-81.18%636.11%
0.00%0.00%0.00%0.00%0.00%0.00%-36.77%-81.18%636.11%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x83.19x278.00x58.46x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x3.43x2.15x3.14x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.19%0.15%0.19%
0.00x0.00x0.00x0.00x0.00x0.00x32.95x43.82x26.49x

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
72.0272.0272.0272.0272.0272.0272.0272.0272.02
3.373.333.363.303.263.404.173.813.93
10.646.836.345.465.113.873.322.993.11
Government0.000.000.000.000.000.000.000.000.00
13.9817.8218.2819.2219.6020.7320.4821.1720.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28
Copy of Newspaper Publication

2026-08-28 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27
Record Date

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026.

2026-08-27
Updates

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding ' Business Responsibility and Sustainability Report for the FY 2025-26'.

2026-08-27
Shareholders meeting

2026-08-27 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

2026-08-19
Resignation of Director/KMP/SMP

2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-19
Resignation

2026-08-19 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Resignation of a Senior Management Personnel of the Company.

2026-08-18
Copy of Newspaper Publication

2026-08-18 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-11
Updates

2026-08-11 - Tatva Chintan Pharma Chem Limited has informed the Exchange regarding 'Communication to Shareholders Final Dividend for FY 2025-26 - Intimation onTax Deduction at source (TDS) / withholding tax on Dividend'.

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for TATVA

Loading news…

🤖

AI Stock Analyst

Tatva Chintan Pharma Chem Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login